|
|
Article: PNP Therapeutics Raises $925,000 in Series B Financing Through Birmingham Technology Fund and Phase 1 Holdings.
- Article from:
- PR Newswire
- Article date:
- June 7, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company prepares for technology to enter Phase 1 clinical trial
BIRMINGHAM, Ala., June 7 /PRNewswire/ -- PNP Therapeutics, Inc. -- a privately held, Birmingham-based, life sciences company -- today announced that it has received $925,000 in Series B financing through the Birmingham Technology Fund, managed by Greer Capital Advisors LLC of Birmingham, and Phase 1 Holdings, LLC managed by Dr. John C. Lankford. PNP also announced that Frank R. Hunt, a member of its Board of Directors, has been named chief executive officer. Dr. Lawrence W. Greer of Greer Capital Advisors has joined the PNP Board of Directors.
"This funding enables PNP Therapeutics to move ...
Related newspaper, magazine, and journal articles:
|
|
Article: e-business: pounds 1m boost for bright ideas.
The Birmingham Post (England);
September 12, 2000 ;
700+ words
... ... England. Derek Harris, chief executive of Birmingham Technology, the controlling company of Aston Science ... Coun Bore is also a member of the board of Birmingham Technology, the science park's management company ...
|
|